Dae Yeon Hwang

Dae Yeon Hwang

Auto-generated profile, based on publicly available information

Dae Yeon Hwang

Kyung Hee Institute of Regenerative Medicine (KIRM), Medical Science Research Institute, Kyung Hee University Medical Center, Republic of Korea

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 October 2017 in Tissue Engineering and Regenerative Medicine
Verified
Journal Article
Open access
PDF file
DHDae Yeon Hwang
Dae Yeon Hwang
SKSuna Kim
Suna Kim
HHHyun Sook Hong
Hyun Sook Hong
Intestinal inflammation alters immune responses in the mucosa and destroys colon architecture, leading to serious diseases such as inflammatory bowel disease. Thus, the modulation of intestinal integrity and immune responses in IBD can be the critical factor to be considered to reduce the severity of damages. Substance-P (SP), endogenous peptide to be involved in cell proliferation, migration and immune modulation, can exert the therapeutic effect on diverse diseases including cornea damage, rheumatoid arthritis and diabetic complications. SP was found to elevate expression of junctional molecule. Considering the function of SP reported previously, it was inferred that SP is capable of exert the beneficial effect of SP on intestinal diseases by controlling intestinal structure as well as immune responses. In this study, we explored the therapeutic effect of SP on dextran sodium sulfate-induced intestine damage by injecting SP. The effects of SP were evaluated by analyzing crypt structures, proliferating cell pool and infiltration of immune cells. DSS treatment provoked abnormal immune response and disruption of intestine epithelial barrier. However, co-treatment of SP obviously blocked the development of intestinal damages by declining inflammatory responses and sustaining intestinal structure more intact. The treatment of SP to chronic damages also promoted intestinal regeneration by preserving the integrity of colon tissue. Moreover, DSS-induced reduction of epithelial junctional molecule was obviously inhibited by SP treatment in vitro. Taken together, our data indicate that SP can reduce intestinal damages, possibly by modulating barrier structure and immune response. Our results propose SP as candidate therapeutics in intestinal damages.

1 May 2019 in Life Sciences
Verified
Journal Article
Closed access
SKSuna Kim
Suna Kim
JPJiyuan Piao
Jiyuan Piao
DHDae Yeon Hwang
Dae Yeon Hwang
JPJeong Seop Park
Jeong Seop Park
YSYoungsook Son
Youngsook Son
HHHyun Sook Hong
Hyun Sook Hong

16 March 2016 in Oncotarget
Verified
Journal Article
Open access
PDF file
HLHyelim Lee
Hyelim Lee
Mi Hee ParkMi Hee Park
Mi Hee Park
JSJu Kyoung Song
Ju Kyoung Song
YJYu Yeon Jung
Yu Yeon Jung
YKYoungsoo Kim
Youngsoo Kim
JHJin Tae Hong
Jin Tae Hong
Tumor growth suppressive effect of IL-4 through p21-mediated activation of STAT6 in IL-4Rα overexpressed melanoma models Tumor growth suppressive effect of IL-4 through p21-mediated activation of STAT6 in IL-4Rα overexpressed melanoma models

29 April 2023 in Oxidative Medicine and Cellular Longevity
Verified
Journal Article
Open access
PDF file
도김도영 김
도영 김
JPJiyuan Piao
Jiyuan Piao
JPJeong Seop Park
Jeong Seop Park
DLDahyun Lee
Dahyun Lee
DHDae Yeon Hwang
Dae Yeon Hwang
HHHyun Sook Hong
Hyun Sook Hong
Estrogen deficiency causes bone loss via diverse pathological cellular events. The involvement of the vasculature in bone formation has been widely studied, and type H vasculature has been found to be closely related to bone healing. Ovariectomy- (OVX-) induced estrogen deficiency reduces type H vessel density and promotes reduction of bone density. Analysis of early events after OVX showed that estrogen deficiency preferentially induces oxidative stress, which might provoke endothelial dysfunction and reduce angiogenic factors systemically and locally. The instability of the vascular potential is expected to promote bone loss under estrogen deficiency. Substance P (SP) is an endogenous neuropeptide that controls inflammation and prevents cell death under pathological conditions. SP can elevate nitric oxide production in endothelial cells and inhibit endothelial dysfunction. This study is aimed at investigating the preventive effects of systemically injected SP on OVX-induced vascular loss and osteoporosis onset. SP was systemically administered to OVX rats twice a week for 4 weeks, immediately after OVX induction. OVX conditions could decrease antioxidant enzyme activity, type H vessels, and angiogenic growth factors in the bone marrow, followed by inflammation and bone loss. However, pretreatment with SP could block type H vessel loss, accompanied by the enrichment of nitric oxide and sustained angiogenic factors. SP-mediated early vascular protection inhibits bone density reduction. Altogether, this study suggests that early administration of SP can block osteoporosis development by modulating oxidative stress and protecting the bone vasculature and angiogenic paracrine potential at the initial stage of estrogen deficiency.